Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Mancini

Showing results (61-70 of 119) with videos related to

Pageof 12
Sort By:
Genes, Chromosomes & Cancer|July 6, 2004
Insertions generating the 5'RUNX1/3'CBFA2T1 gene in acute myeloid leukemia cases show variable breakpointsGiorgina Specchia, Francesco Albano, Luisa Anelli, et al.
Leukemia & Lymphoma|April 6, 2011
Isodicentric duplication of Philadelphia chromosome as a mechanism of resistance to dasatinib in a patient with chronic myeloid leukemia after resistance to imatinibGiuseppina Loglisci, Massimo Breccia, Mauro Nanni, et al.
Cancer Cell|November 13, 2007
Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoproteinFrancesco Fazi, Serena Racanicchi, Giuseppe Zardo, et al.
Genes, Chromosomes & Cancer|August 31, 2004
A new complex rearrangement involving the ETV6, LOC115548, and MN1 genes in a case of acute myeloid leukemiaElena Belloni, Maurizio Trubia, Marco Mancini, et al.
Plos One|June 10, 2010
Prevalence and clinical significance of HIV drug resistance mutations by ultra-deep sequencing in antiretroviral-naïve subjects in the CASTLE studyMax Lataillade, Jennifer Chiarella, Rong Yang, et al.
Lancet (London, England)|August 30, 2008
Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE studyJean-Michel Molina, Jaime Andrade-Villanueva, Juan Echevarria, et al.
Frontiers in Neuroergonomics|January 18, 2024
Neuroscientific Methods for Exploring User Perceptions While Dealing With Mobile Advertising: A Novel and Integrated ApproachMarco Mancini, Patrizia Cherubino, Gianluca di Flumeri, et al.
Brain Sciences|March 6, 2021
Forefront Users' Experience Evaluation by Employing Together Virtual Reality and Electroencephalography: A Case Study on Cognitive Effects of ScentsMarco Mancini, Patrizia Cherubino, Giulia Cartocci, et al.
Mediterranean Journal of Hematology and Infectious Diseases|December 4, 2012
Ara-C, Idarubicine and Gentuzumab Ozogamicin (AIM) as Salvage Treatment in Advanced Acute Myeloid Leukemia PatientsSaveria Capria, Silvia Maria Trisolini, Clara Minotti, et al.
International Journal of Biometeorology|August 1, 2023
Temperature-humidity index monitoring during two summer seasons in dairy cow sheds in Mugello (Tuscany)Alessandro Messeri, Marco Mancini, Riccardo Bozzi, et al.
Pageof 12

Showing results (61-70 of 119) with videos related to

Sort By:
Pageof 12
Genes, Chromosomes & Cancer|July 6, 2004
Insertions generating the 5'RUNX1/3'CBFA2T1 gene in acute myeloid leukemia cases show variable breakpointsGiorgina Specchia, Francesco Albano, Luisa Anelli, et al.
Leukemia & Lymphoma|April 6, 2011
Isodicentric duplication of Philadelphia chromosome as a mechanism of resistance to dasatinib in a patient with chronic myeloid leukemia after resistance to imatinibGiuseppina Loglisci, Massimo Breccia, Mauro Nanni, et al.
Cancer Cell|November 13, 2007
Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoproteinFrancesco Fazi, Serena Racanicchi, Giuseppe Zardo, et al.
Genes, Chromosomes & Cancer|August 31, 2004
A new complex rearrangement involving the ETV6, LOC115548, and MN1 genes in a case of acute myeloid leukemiaElena Belloni, Maurizio Trubia, Marco Mancini, et al.
Plos One|June 10, 2010
Prevalence and clinical significance of HIV drug resistance mutations by ultra-deep sequencing in antiretroviral-naïve subjects in the CASTLE studyMax Lataillade, Jennifer Chiarella, Rong Yang, et al.
Lancet (London, England)|August 30, 2008
Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE studyJean-Michel Molina, Jaime Andrade-Villanueva, Juan Echevarria, et al.
Frontiers in Neuroergonomics|January 18, 2024
Neuroscientific Methods for Exploring User Perceptions While Dealing With Mobile Advertising: A Novel and Integrated ApproachMarco Mancini, Patrizia Cherubino, Gianluca di Flumeri, et al.
Brain Sciences|March 6, 2021
Forefront Users' Experience Evaluation by Employing Together Virtual Reality and Electroencephalography: A Case Study on Cognitive Effects of ScentsMarco Mancini, Patrizia Cherubino, Giulia Cartocci, et al.
Mediterranean Journal of Hematology and Infectious Diseases|December 4, 2012
Ara-C, Idarubicine and Gentuzumab Ozogamicin (AIM) as Salvage Treatment in Advanced Acute Myeloid Leukemia PatientsSaveria Capria, Silvia Maria Trisolini, Clara Minotti, et al.
International Journal of Biometeorology|August 1, 2023
Temperature-humidity index monitoring during two summer seasons in dairy cow sheds in Mugello (Tuscany)Alessandro Messeri, Marco Mancini, Riccardo Bozzi, et al.
Pageof 12